Fulgent Genetics SG&A Expense (Quarterly) Analysis

Fulgent Genetics Inc (FLGT)

21.79 +0.52 (+2.44%) USD | NASDAQ | May 09, 16:00

21.76 -0.04 (-0.16%) After-Hours: 20:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2015. Upgrade now.

Date	Value
March 31, 2024	30.48M
December 31, 2023	42.21M
September 30, 2023	27.66M
June 30, 2023	28.72M
March 31, 2023	31.88M
December 31, 2022	39.05M
September 30, 2022	36.12M
June 30, 2022	41.11M
March 31, 2022	33.72M
December 31, 2021	30.30M
September 30, 2021	18.31M
June 30, 2021	13.55M
March 31, 2021	13.01M
December 31, 2020	12.72M
September 30, 2020	8.755M
June 30, 2020	5.059M
March 31, 2020	3.632M
December 31, 2019	3.367M

Date	Value
September 30, 2019	3.209M
June 30, 2019	2.935M
March 31, 2019	2.801M
December 31, 2018	2.507M
September 30, 2018	2.421M
June 30, 2018	2.645M
March 31, 2018	2.617M
December 31, 2017	2.482M
September 30, 2017	2.588M
June 30, 2017	1.991M
March 31, 2017	2.377M
December 31, 2016	1.913M
September 30, 2016	2.04M
June 30, 2016	0.934M
March 31, 2016	2.19M
December 31, 2015	3.87M
September 30, 2015	0.496M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

2.935M

Minimum

Jun 2019

42.21M

Maximum

Dec 2023

21.29M

Average

22.98M

Median

SG&A Expense (Quarterly) Benchmarks